Summary of the National Advisory Committee on Immunization’s Update on the recommended human papillomavirus (HPV) vaccine immunization schedule

Ítems similars

• Summary of the National Advisory Committee on Immunization’s updated recommendations on human papillomavirus (HPV) vaccines: Nine-valent human papillomavirus (HPV) of minimum intervals between doses in the HPV immunization schedule
  per: Tunis, MC, et al.
  Publicat: (2016)
• Summary of the NACI Update on the recommended use of Human Papillomavirus (HPV) vaccine: Nine-valent HPV vaccine two-dose immunization schedule and the use of HPV vaccines in immunocompromised populations
  per: Deeks, SL, et al.
  Publicat: (2017)
• Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS)National Advisory Committee on Immunization (NACI)(†)
  per: Dawar, Dr. M., et al.
  Publicat: (2012)
• Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
  per: Petrosky, Emiko, et al.
  Publicat: (2015)
• Summary of the National Advisory Committee on Immunization’s Update on quadrivalent meningococcal vaccines available in Canada
  per: Henry, B
  Publicat: (2015)